Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deferred Tax LiabilityOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Strata Critical Medical (SRTA) Receivables (2020 - 2025)

Strata Critical Medical (SRTA) has disclosed Receivables for 6 consecutive years, with $40.0 million as the latest value for Q4 2025.

  • Quarterly Receivables rose 101.58% to $40.0 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $40.0 million through Dec 2025, up 101.58% year-over-year, with the annual reading at $40.0 million for FY2025, 101.58% up from the prior year.
  • Receivables for Q4 2025 was $40.0 million at Strata Critical Medical, up from $37.5 million in the prior quarter.
  • The five-year high for Receivables was $40.0 million in Q4 2025, with the low at $1.7 million in Q2 2021.
  • Average Receivables over 5 years is $18.6 million, with a median of $21.0 million recorded in 2023.
  • The sharpest move saw Receivables skyrocketed 464.95% in 2022, then decreased 6.04% in 2025.
  • Over 5 years, Receivables stood at $5.5 million in 2021, then surged by 96.05% to $10.9 million in 2022, then skyrocketed by 93.11% to $21.0 million in 2023, then fell by 5.63% to $19.8 million in 2024, then soared by 101.58% to $40.0 million in 2025.
  • According to Business Quant data, Receivables over the past three periods came in at $40.0 million, $37.5 million, and $28.2 million for Q4 2025, Q3 2025, and Q2 2025 respectively.